Established technology platforms of RT-PCR, chemiluminescence immunoassay and fluorescence immunoassay
Approved as Provincial High-tech Enterprise R&D Center
Approved as Hangzhou Patent Pilot Enterprise
Obtained US FDA 510(k) Clearances
Brand new R&D and production base completed
Obtained ISO 9001 quality management system certification
Approved as National High-tech Enterprise
Obtained CE certification and ISO 13485 medical device quality management system certification
Obtained China Medical Device Manufacturer License
Established technology platforms of colloidal gold immunoassay and ELISA
Clongene Biotech Co., Ltd. was established
Established technology platforms of genetic engineering, monoclonal antibody and polyclonal antibody